Chirochem (Taizhou) Pharmaceutical R&D Ltd.
Chirochem (Taizhou) Pharmaceutical R&D Ltd (hereinafter referred to as LCC Taizhou) was established in April 2015 based in Taizhou China, wholly funded by Liverpool ChiroChem Ltd (UK). LCC Taizhou is a chemical technology innovator that produces chiral small molecules for pharmaceutical R&D. Main businesses of LCC Taizhou include: design, synthesis and sales of novel chiral building blocks for innovative drug R&D; process development, pilot test, manufacturing and sales of core chiral intermediates for generic drug R&D.

Chirochem (Taizhou) Pharmaceutical R&D Ltd.